Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications
- 1 September 2000
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 17 (9) , 650-656
- https://doi.org/10.1046/j.1464-5491.2000.00350.x
Abstract
SUMMARY Aims To evaluate serum levels of vascular endothelial growth factor (VEGF) in a large group of children, adolescents and young adults with Type 1 diabetes mellitus to investigate whether increased VEGF concentrations are associated with long‐term glycaemic control and microvascular complications.Methods The study involved 196 patients with Type 1 diabetes mellitus (age range 2–24 years, onset of diabetes before the age of 12 years, duration of disease longer than 2 years), without clinical and laboratory signs of microvascular complications; they were divided into three groups (group 1 –n = 37, age < 6 years; group 2 –n = 71, age 6–12 years; group 3 –n = 88–age > 12 years). Fifty‐three adolescents and young adults (age 16.1–29.7) with different grades of diabetic retinopathy and microalbuminuria were also selected (group 4). A total of 223 healthy controls were matched for age and sex with each group of patients with diabetes mellitus.Results VEGF serum levels were significantly increased in pre‐school and pre‐pubertal children with diabetes as well as in pubertal patients compared to controls. VEGF concentrations were markedly increased in adolescents and young adults with microvascular complications compared with both healthy controls and diabetic patients without retinopathy or nephropathy. Multivariate analysis showed that elevation of VEGF in serum was an independent correlate of complications. One‐year mean HbA1c values were significantly correlated with VEGF concentrations (r = 0.372; P < 0.01). Children with HbA1c levels greater than 10% had significantly higher VEGF concentrations when compared with matched patients whose HbAlc levels were lower than 10%. In poorly controlled diabetic children (HbA1c > 10%), long‐term (2 years) improvement of glycaemic control (aiming at HbA1c < 7%) resulted in a significant reduction of VEGF levels.Conclusions VEGF serum concentrations are increased in prepubertal and pubertal children with diabetes. Glycaemic control influences VEGF serum levels. Severity of microvascular complications is associated with marked increase of VEGF concentrations in the serum of these patients.Keywords
This publication has 36 references indexed in Scilit:
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Vascular Endothelial Growth Factor Is Up-Regulatedin Vitroandin Vivoby AndrogensBiochemical and Biophysical Research Communications, 1998
- Advanced glycation end products increase retinal vascular endothelial growth factor expression.Journal of Clinical Investigation, 1998
- Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.Journal of Clinical Investigation, 1997
- Vascularised vitreoretinopathy: The role of growth factorsEye, 1996
- The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeabilityBiochimica et Biophysica Acta (BBA) - General Subjects, 1995
- Significance of Vascular Endothelial Growth Factor/Vascular Permeability Factor for Solid Tumor Growth, and Its Inhibition by the AntibodyBiochemical and Biophysical Research Communications, 1993
- Molecular and biological properties of the vascular endothelial growth factor family of proteinsEndocrine Reviews, 1992
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.Journal of Clinical Investigation, 1989